DNA sequencing is a molecular technique that helps determine the nucleotide sequence of DNA (deoxyribonucleic acid), which is the most fundamental level of knowledge of a gene or genome. The global DNA sequencing market accounted for $6,243 million in 2017, and is anticipated to reach $25,470 million by 2025, registering a CAGR of 19.0% from 2017 to 2025. DNA sequencing has revolutionized molecular biology and genomics research. The knowledge of DNA sequences of genes and other parts of the genome of organisms has become essential for life-science research and also in applied fields, such as forensics, cancer diagnostics, and others. Through this method, billions of DNA strands can be sequenced efficiently. DNA sequencing has made it possible to conveniently sequence whole genomes and analyze various DNA-protein interactions. This technique allows the researcher to focus, study, and interpret deep sequence target regions. They are utilized through varied interventions, such as oncology, biomarker studies, drug discovery, understanding reproductive health, and personalized genomics.
Major Key Players of the DNA sequencing Market are:
Abbott Laboratories, Agilent Technologies, Inc., Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc, LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG; PerkinElmer Inc., Thermo Fisher Scientific, Inc.
No comments:
Post a Comment